Kolexia
Desmoulins Isabelle Oncologie médicale
Desmoulins Isabelle
Oncologie médicale
Centre Georges-François Leclerc
Dijon, France
223 Activités
350 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Tumeurs du sein triple-négatives Métastase tumorale Récidive tumorale locale Carcinome canalaire du sein Carcinomes Carcinome lobulaire Tumeur du sein de l'homme Métastase lymphatique

Collaborateurs

Voir plus
Levy Christelle
Levy Christelle
Centre François-Baclesse, Caen, France
Goncalves Anthony
Goncalves Anthony
Centre Paoli-Calmettes, Marseille, France
Ferrero Jean Marc
Ferrero Jean Marc
Centre Antoine Lacassagne, Nice, France
Bachelot Thomas
Bachelot Thomas
Centre Léon-Bérard, Lyon, France

Industries

Voir plus
Seagen
18 collaboration(s)
Dernière en 2023
Lilly
14 collaboration(s)
Dernière en 2023
Daiichi Sankyo
8 collaboration(s)
Dernière en 2023
Novartis
5 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
HER2CLIMB-05: A Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy for Metastatic HER2+ Breast Cancer (HER2CLIMB-05)
Essai Clinique (Seagen)   15 mars 2024
ETIC-LM: Multicentric Single Arm Phase II Study Evaluating the Efficacy of Association of Tucatinib, Capecitabine and Intra-CSF Trastuzumab in HER2 Amplified Breast Cancer Patients With Leptomeningeal Metastases
Essai Clinique (Seagen)   02 février 2024
Pathologic and immunohistochemical prognostic markers in residual triple-negative breast cancer after neoadjuvant chemotherapy.
Frontiers in oncology   10 janvier 2024
Carboplatin and Etoposide for the Treatment of Metastatic Prostate Cancer with or without Neuroendocrine Features: A French Single-Center Experience.
Cancers   09 janvier 2024
EXOSARC: Study of Exosomes in Monitoring Patients With Sarcoma (EXOSARC)
Essai Clinique (Centre Georges-François Leclerc)   11 décembre 2023
First-line real-world treatment patterns and survival outcomes in women younger or older than 40 years with metastatic breast cancer in the real-life multicenter French ESME cohort.
European journal of cancer (Oxford, England : 1990)   10 novembre 2023
PREDIGOSTEO: Osteopathy and Prevention of Gastrointestinal Side Effects of the Adjuvant Treatment FEC in Women Treated in Day Hospital for Breast Cancer
Essai Clinique (Centre Georges-François Leclerc)   16 octobre 2023
Real-World Impact of Adjuvant Anti-HER2 Treatment on Characteristics and Outcomes of Women With HER2-Positive Metastatic Breast Cancer in the ESME Program.
The oncologist   11 octobre 2023
255P Prognostic stratification capacity of the CPS+EG scoring system in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
PEMBROCABOSARC: Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas
Essai Clinique (Ipsen)   27 septembre 2023